Emerging Therapies for Cerebrovascular Disorders
- 1 February 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (2) , 367-369
- https://doi.org/10.1161/01.str.0000115296.67346.28
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Effects of a Perindopril-Based Blood Pressure–Lowering Regimen on Disability and Dependency in 6105 Patients With Cerebrovascular DiseaseStroke, 2003
- Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatmentThe Lancet, 2003
- Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialThe Lancet, 2003
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Use of ramipril in preventing stroke: double blind randomised trialBMJ, 2002
- HMG-CoA reductase inhibitors (statins)Neurology, 2000